Jeevan Scientific Technology's Clinical Pharmacology Centre gets approved by DCGI

To conduct end-to-end Bioequivalence studies

Jeevan Scientific Technology announced that the Company's Clinical Pharmacology Centre to conduct Bioavailability/Bioequivalence studies has been approved by the Office of Drug Control General, India (DCGI) on 16 December 2016 for a period of Three (3) years.

This Centre having four independent clinics having a total capacity of 132 beds will facilitate end-to-end Bioequivalence studies by Jeevan Scientific Technology.

Powered by Capital Market - Live News